HealthDay News — For the commercially-insured pediatric population in the United States, the prevalence of diabetes and diabetic nephropathy increased from 2002 to 2013, according to a study published in Diabetes Care.
Lin Li, MD, PhD, from the Boston University School of Public Health, and colleagues examined the prevalence of diabetes and diabetic nephropathy in pediatric patients aged <18 years from 2002 to 2013. The authors identified 96 171 pediatric patients with diabetes and 3161 pediatric patients with diabetic nephropathy using the US MarketScan commercial claims database.
The researchers found that during 2002 to 2013 there was an increase in the annual prevalence of diabetes from 1.86 to 2.82 per 1000.
In pediatric patients with diabetes, the annual prevalence of diabetic nephropathy increased from 2002 to 2013: from 1.16 to 3.44% for all cases and from 0.83 to 2.32% for probable cases only. Patients aged 12 to <18 years had the highest prevalence of diabetes and diabetic nephropathy.
The prevalence of type 1 diabetes was higher in male than female youth, while type 2 diabetes and diabetic nephropathy prevalence was higher in females versus males.
The prevalence of diabetic nephropathy did not vary with diabetes type.
“The prevalence of diabetes and diabetic nephropathy increased in the U.S. MarketScan commercially-insured pediatric population from 2002 to 2013,” the authors write.
Several authors disclosed financial ties to Bayer Pharma, which provided study funding.
Li L, Jick S, Breitenstein S, Michel A. Prevalence of Diabetes and Diabetic Nephropathy in a Large U.S. Commercially Insured Pediatric Population, 2002–2013. Diabetes Care. 2015:dc151710. doi:10.2337/dc15-1710.